<VariationArchive VariationID="2755870" VariationName="NM_000101.4(CYBA):c.109dup (p.Tyr37fs)" VariationType="Duplication" Accession="VCV002755870" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-20" DateCreated="2024-02-14" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2917042" VariationID="2755870">
      <GeneList>
        <Gene Symbol="CYBA" FullName="cytochrome b-245 alpha chain" GeneID="1535" HGNC_ID="HGNC:2577" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16q24.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="88643289" stop="88651053" display_start="88643289" display_stop="88651053" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="88709696" stop="88717491" display_start="88709696" display_stop="88717491" Strand="-" />
          </Location>
          <OMIM>608508</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000101.4(CYBA):c.109dup (p.Tyr37fs)</Name>
      <CanonicalSPDI>NC_000016.10:88648063:A:AA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>16q24.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="88648063" stop="88648064" display_start="88648063" display_stop="88648064" variantLength="1" positionVCF="88648063" referenceAlleleVCF="T" alternateAlleleVCF="TA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="88714471" stop="88714472" display_start="88714471" display_stop="88714472" variantLength="1" positionVCF="88714471" referenceAlleleVCF="T" alternateAlleleVCF="TA" />
      </Location>
      <ProteinChange>Y37fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.88648064dup" Assembly="GRCh38">
            <Expression>NC_000016.10:g.88648064dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.88714472dup" Assembly="GRCh37">
            <Expression>NC_000016.9:g.88714472dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007291.1" sequenceAccession="NG_007291" sequenceVersion="1" change="g.7986dup">
            <Expression>NG_007291.1:g.7986dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000101.4" sequenceAccession="NM_000101" sequenceVersion="4" change="c.109dup" MANESelect="true">
            <Expression>NM_000101.4:c.109dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000092.2" sequenceAccession="NP_000092" sequenceVersion="2" change="p.Tyr37fs">
            <Expression>NP_000092.2:p.Tyr37fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_52" sequenceAccession="LRG_52">
            <Expression>LRG_52:g.7986dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_52t1" sequenceAccession="LRG_52t1">
            <Expression>LRG_52t1:c.109dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_52p1" sequenceAccession="LRG_52p1" change="p.Tyr37Leufs">
            <Expression>LRG_52p1:p.Tyr37Leufs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000101.4(CYBA):c.109dup (p.Tyr37fs) AND Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative" Accession="RCV003498480" Version="1">
        <ClassifiedConditionList TraitSetID="578">
          <ClassifiedCondition DB="MedGen" ID="C1856255">Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-08-29" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-08-29" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-02-14" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="578" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1396" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative</ElementValue>
                <XRef ID="Granulomatous+disease%2C+chronic%2C+autosomal+recessive%2C+cytochrome+b-negative/8493" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009308" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, 4</ElementValue>
                <XRef Type="MIM" ID="233690" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608508.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608508.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608508.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608508.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608508.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608508.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608508.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608508.0012" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608508.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608508.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608508.0003" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CGD DUE TO DEFICIENCY OF THE ALPHA SUBUNIT OF CYTOCHROME b</ElementValue>
                <XRef Type="MIM" ID="233690" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CGD, AUTOSOMAL RECESSIVE CYTOCHROME b-NEGATIVE</ElementValue>
                <XRef Type="MIM" ID="233690" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CYBA DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="233690" DB="OMIM" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Chronic granulomatous disease (CGD) is a primary immunodeficiency disorder of phagocytes (neutrophils, monocytes, macrophages, and eosinophils) resulting from impaired killing of bacteria and fungi. CGD is characterized by severe recurrent bacterial and fungal infections and dysregulated inflammatory responses resulting in granuloma formation and other inflammatory disorders such as colitis. Infections typically involve the lung (pneumonia), lymph nodes (lymphadenitis), liver (abscess), bone (osteomyelitis), and skin (abscesses or cellulitis). Granulomas typically involve the genitourinary system (bladder) and gastrointestinal tract (often the pylorus initially, and later the esophagus, jejunum, ileum, cecum, rectum, and perirectal area). Some males with X-linked CGD have McLeod neuroacanthocytosis syndrome as the result of a contiguous gene deletion. While CGD may present anytime from infancy to late adulthood, the vast majority of affected individuals are diagnosed before age five years. Use of antimicrobial prophylaxis and therapy has greatly improved overall survival.</Attribute>
                <XRef ID="NBK99496" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15175" />
                <XRef ID="15175" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">22876374</ID>
                <ID Source="BookShelf">NBK99496</ID>
              </Citation>
              <XRef ID="379" DB="Orphanet" />
              <XRef ID="C1856255" DB="MedGen" />
              <XRef ID="MONDO:0009308" DB="MONDO" />
              <XRef Type="MIM" ID="233690" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="8005162" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2024-02-14">
        <ClinVarSubmissionID localKey="27087914|MedGen:C1856255" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004320567" DateUpdated="2024-02-14" DateCreated="2024-02-14" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-08-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. This variant disrupts a region of the CYBA protein in which other variant(s) (p.Glu129*) have been determined to be pathogenic (Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with CYBA-related conditions. This sequence change results in a frameshift in the CYBA gene (p.Tyr37Leufs*176). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 159 amino acid(s) of the CYBA protein and extend the protein by 16 additional amino acid residues. This variant is not present in population databases (gnomAD no frequency).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CYBA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000016.9:g.88714471_88714472insA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1856255" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8005162" TraitType="Disease" MappingType="XRef" MappingValue="C1856255" MappingRef="MedGen">
        <MedGen CUI="C1856255" Name="Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

